Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
acute, allocating, allocation, arrive, autoimmune, boost, Bulletin, cast, catalog, chronic, Clark, Codification, content, Crohn, debenture, Default, delinquent, Distinguishing, dual, error, escrow, excessive, extracellular, forma, frequently, fulfill, goodwill, hand, Hospital, hypoxia, immune, immunity, immunosuppression, implicated, inflammation, inflammatory, Informationcontained, inhibition, IO, ischemia, LifeTech, LNC, macroeconomic, mandatorily, mediated, methodology, microenvironment, misstatement, modulator, Montgomery, navigating, ninety, noncontrolling, NYU, OCT, pain, PCAOB, pink, preceding, qualitative, receptor, recommence, redeem, redeemable, renew, repay, repurchase, Resume, rheumatoid, Ridgeway, role, ROU, run, seeEquity, signaling, synthesized, tissue, trauma, unaudited, Virginia, vital, Winthrop
Removed:
AB, Abbott, ablation, ABLX, Ablynx, academic, accident, accidental, acreage, activated, ad, Adult, Agriculture, American, animal, antibody, antigen, ApS, ascertain, assessing, attach, attaching, attack, attained, Austin, Australia, Avastin, avoiding, aware, Barbara, Baton, bid, binding, biochemistry, biopharma, biotech, Biovitrum, block, blood, bloodstream, bone, borrowed, BS, budget, calcium, called, carcinoma, cell, center, central, Cephalon, chairman, chemical, chemically, chemotherapeutic, choice, Christensen, clinically, closed, CMC, CNS, coastal, collapse, collect, comparison, competitor, Complexa, component, composed, compound, conclusion, condensed, Consortium, constitute, consummation, contamination, contractor, convert, COO, Cornell, Council, coupled, cultivate, cultivation, curable, cytotoxin, decreasing, dedicated, deep, delivering, demonstrated, Department, derived, designing, destroy, destroying, destruction, Diego, digestive, discharge, disposing, disrupt, distributed, division, dose, dosing, double, Eagle, embolization, endothelial, engineering, enroll, enrollment, entitle, environmental, enzymatically, enzyme, episodic, epithelial, EURONEXT, excise, exhibiting, expiration, export, exposure, extracted, Factor, failed, farming, fast, feasibility, feel, formation, found, fraction, Francisco, fromThapsia, garganica, Gastrointestinal, germination, Glandular, glioblastoma, GmbH, goal, governing, greenhouse, growing, growThapsia, hair, handle, handling, Harrington, harvest, harvesting, hepatocellular, higher, hoc, Hong, Hyperion, Ib, IGC, import, Importantly, importation, importing, importingThapsia, inability, inactive, Incidence, Incomplete, infection, inhibitor, initiate, INN, insight, insignificant, insoluble, Institute, instrumental, Interrupting, intervention, intracellular, Japan, Kallikrein, Karolinska, KDEV, kill, Kong, land, layer, liable, localized, locate, location, Louisiana, low, lump, malignant, manufacturer, marker, marrow, mask, masking, median, Mediterranean, membrane, metabolic, metastatic, minimized, misleading, modify, Molecular, monoclonal, moving, multicenter, natural, naturally, nearby, Newron, Nexavar, Nonproprietary, notified, nutrient, nutrition, NV, NWRN, ofThapsia, omitted, OMX, ongoingThapsia, Onxeo, ONXEONASDAQ, Optimer, Orphazyme, overcome, oxygenation, parachute, partnership, patented, peptide, physical, physiological, Phyton, pilot, placebo, plant, poor, possessing, poster, potent, powerful, precursor, predominantly, preferably, preferentially, prescribed, producing, Profiling, progression, progressive, project, protein, PSA, PSMA, pump, radiation, recognize, recommended, recurrent, refinement, region, regional, relation, renal, repeated, resection, resistance, rest, resulted, reticulum, reversing, Rorer, Rouge, SA, Samuel, Santa, Sea, Secretary, secreted, secureThapsia, SERCA, session, short, side, SL, slowly, SOBI, Society, soluble, sorafenib, specialty, spread, stable, starving, STO, storage, storing, straightforward, structure, sum, supplier, supporting, surface, surgery, survival, suspension, sustainable, Sutent, Swedish, Symposium, tested, Teva, Thapsia, thapsigargin, thatThapsia, therapeutically, therapy, thethapsia, tier, TopoTarget, toxic, toxicity, tract, transplant, treating, triphosphastase, undergraduate, unique, urology, USDA, usThapsia, validate, Validated, vascular, vessel, violate, website, wild, world, Zybrestat
Filing tables
Filing exhibits
- 10-K Annual report
- 3.08 Exhibit 3.08(I)
- 4.45 Exhibit 4.45
- 10.23 Exhibit 10.23
- 14.01 Exhibit 14.01
- 21.01 Exhibit 21.01
- 23.01 Exhibit 23.01
- 31.1 Exhibit 31.1
- 31.2 Exhibit 31.2
- 32.1 Exhibit 32.1
- 32.2 Exhibit 32.2
- 99.01 Exhibit 99.01
- 99.02 Exhibit 99.02
- 99.03 Exhibit 99.03
- Download Excel data file
- View Excel data file
RBSH similar filings
Filing view
External links
Exhibit 23.01
CONSENT OF INDEPENDENT REGISTERED CERTIFIED PUBLIC ACCOUNTANTS
We hereby consent to the incorporation by reference in on Registration Statement on Form S-8 (SEC File No. 333-192553) of Inspyr Therapeutics, Inc. of our report which includes an explanatory paragraph expressing substantial doubt regarding the Company’s ability to continue as a going concern dated April 26, 2019, relating to our audit of the financial statements which appear in this Annual report on Form 10-K of Inspyr Therapeutics, Inc. for the year ended December 31, 2017 and 2016.
/s/ Liggett & Webb, P.A.
April 26, 2019
New York, New York